secwatch.observer — SEC 8-K summary
======================================

Issuer:     SERA PROGNOSTICS, INC. (SERA)
CIK:        0001534969
Form:       8-K
Filed at:   2023-05-10T23:59:59+00:00
Accession:  0001534969-23-000050
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sera Prognostics Q1 revenue $100K, net loss $10.6M; AVERT trial positive
------------------------------------------------------------------------

- Revenue $100K, up 163% from $38K in Q1 2022.
- Net loss narrowed to $10.6M from $12.2M YoY.
- Cash and securities $100M; R&D spend $4.1M (up), SG&A $7.3M (down).
- Positive AVERT PRETERM TRIAL topline results announced in February.
- Physician orders increasing; PRIME study interim look expected by year-end.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534969/000153496923000050/0001534969-23-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534969/000153496923000050/sera-20230510.htm
  HTML page:      https://secwatch.observer/filing/0001534969-23-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer